Literature DB >> 29053398

The involvement of lncRNAs in the development and progression of pancreatic cancer.

Li Duguang1, He Jin2, Qian Xiaowei2, Xu Peng3, Wang Xiaodong3, Li Zhennan3, Qian Jianjun3, Yao Jie3.   

Abstract

Pancreatic cancer is one of the most malignant tumors that are difficult to diagnose at its early stage and there is no effective therapy. Recent studies uncovered that many non-protein-coding RNAs including the class of long noncoding RNAs (lncRNAs) are differentially expressed in various types of tumors and they are potent regulators of tumor progression and metastasis. LncRNA can mediate tumor initiation, proliferation, migration and metastasis through modulating epigenetic modification, alternative splicing, transcription, and protein translation. In this review, we discuss the molecular mechanism of lncRNAs in the involvement of tumor growth, survival, epithelial-mesenchymal transition, tumor microenvironment, cancer stem cells and chemoresistance in pancreatic ductal adenocarcinoma (PDAC).

Entities:  

Keywords:  Cancer Stem Cells; Chemoresistance; EMT; Hypoxia; Long-non-coding RNAs (lncRNAs); Pancreatic Ductal Adenocarcinoma (PDAC); Pancreatic cancer; Tumor Microenvironment

Mesh:

Substances:

Year:  2017        PMID: 29053398      PMCID: PMC5718823          DOI: 10.1080/15384047.2017.1385682

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  118 in total

1.  Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.

Authors:  Yue Wang; Zhenyu Xu; Junfeng Jiang; Chen Xu; Jiuhong Kang; Lei Xiao; Minjuan Wu; Jun Xiong; Xiaocan Guo; Houqi Liu
Journal:  Dev Cell       Date:  2013-03-28       Impact factor: 12.270

2.  Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.

Authors:  Xi Zhou; Qin Gao; Jianzhong Wang; Xin Zhang; Kaige Liu; Zhao Duan
Journal:  Gynecol Oncol       Date:  2014-02-28       Impact factor: 5.482

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.

Authors:  Yifan Lian; Juan Wang; Jing Feng; Jie Ding; Zhonghua Ma; Juan Li; Peng Peng; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2016-09-19

5.  Sonic hedgehog promotes desmoplasia in pancreatic cancer.

Authors:  Jennifer M Bailey; Benjamin J Swanson; Tomofumi Hamada; John P Eggers; Pankaj K Singh; Thomas Caffery; Michel M Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

6.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a.

Authors:  Peng Jia; Heng Cai; Xiaobai Liu; Jiajia Chen; Jun Ma; Ping Wang; Yunhui Liu; Jian Zheng; Yixue Xue
Journal:  Cancer Lett       Date:  2016-08-16       Impact factor: 8.679

Review 8.  The ever-expanding role of HIF in tumour and stromal biology.

Authors:  Edward L LaGory; Amato J Giaccia
Journal:  Nat Cell Biol       Date:  2016-04       Impact factor: 28.824

9.  The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

Authors:  S Muenst; S D Soysal; F Gao; E C Obermann; D Oertli; W E Gillanders
Journal:  Breast Cancer Res Treat       Date:  2013-06-12       Impact factor: 4.872

10.  ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.

Authors:  Song Gao; Peng Wang; Yongqiang Hua; Hao Xi; Zhiqiang Meng; Te Liu; Zhen Chen; Luming Liu
Journal:  Oncotarget       Date:  2016-01-12
View more
  31 in total

1.  Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.

Authors:  Yuan-Chi Weng; Jin Ma; Jun Zhang; Jian-Cheng Wang
Journal:  Cancer Biol Ther       Date:  2018-12-22       Impact factor: 4.742

2.  Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling.

Authors:  Zhengle Zhang; Erhu Fang; Yuping Rong; Han Han; Qiong Gong; Yingyan Xiao; Hehe Li; Pei Mei; Hanjun Li; Zhongchao Zhu; Zhigang Tang; Jing Tao
Journal:  Am J Cancer Res       Date:  2021-01-01       Impact factor: 6.166

3.  Role of Curcumin in Regulating Long Noncoding RNA Expression in Cancer.

Authors:  Abolfazl Amini; Parand Khadivar; Ali Ahmadnia; Morteza Alipour; Muhammed Majeed; Tannaz Jamialahmadi; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Emerging Role of Exosomal-Derived Long Noncoding RNAs in Human PDAC.

Authors:  Di Long; Xiao Dong Tian; Yin-Mo Yang
Journal:  Visc Med       Date:  2021-12-20

5.  Long noncoding RNA IRAIN acts as tumor suppressor via miR-125b in multiple myeloma.

Authors:  Yanxia Jiang; Jian Chen; Guoan Chen
Journal:  Oncol Lett       Date:  2019-10-21       Impact factor: 2.967

6.  Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis.

Authors:  Bin Wang; Xing Sun; Ke-Jian Huang; Li-Sheng Zhou; Zheng-Jun Qiu
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

Review 7.  Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress.

Authors:  Raúl Ortíz; Francisco Quiñonero; Beatriz García-Pinel; Marco Fuel; Cristina Mesas; Laura Cabeza; Consolación Melguizo; Jose Prados
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

8.  YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.

Authors:  Zhen Yang; Hongjian Ding; Zhiyu Pan; Huaqing Li; Junbin Ding; Qian Chen
Journal:  Cancer Biol Ther       Date:  2021-03-08       Impact factor: 4.742

Review 9.  Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma.

Authors:  Xiu Hu; Wei Chen
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 10.  Long noncoding RNAs: role and contribution in pancreatic cancer.

Authors:  K T Ramya Devi; Dharshene Karthik; TharunSelvam Mahendran; M K Jaganathan; Sanjana Prakash Hemdev
Journal:  Transcription       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.